These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 16775035)
1. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035 [TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved. Golbang AP; Cope G; Hamad A; Murthy M; Liu CH; Cuthbert AW; O'shaughnessy KM Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1369-76. PubMed ID: 16788137 [TBL] [Abstract][Full Text] [Related]
3. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707 [TBL] [Abstract][Full Text] [Related]
4. Role of WNK4 and kidney-specific WNK1 in mediating the effect of high dietary K Wu P; Gao ZX; Su XT; Ellison DH; Hadchouel J; Teulon J; Wang WH Am J Physiol Renal Physiol; 2018 Aug; 315(2):F223-F230. PubMed ID: 29667910 [TBL] [Abstract][Full Text] [Related]
5. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Lazrak A; Liu Z; Huang CL Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1615-20. PubMed ID: 16428287 [TBL] [Abstract][Full Text] [Related]
6. The acidic motif of WNK4 is crucial for its interaction with the K channel ROMK. Murthy M; Cope G; O'Shaughnessy KM Biochem Biophys Res Commun; 2008 Oct; 375(4):651-4. PubMed ID: 18755144 [TBL] [Abstract][Full Text] [Related]
7. Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. Cheng CJ; Huang CL J Am Soc Nephrol; 2011 Mar; 22(3):460-71. PubMed ID: 21355052 [TBL] [Abstract][Full Text] [Related]
8. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase. Liu Z; Wang HR; Huang CL J Biol Chem; 2009 May; 284(18):12198-206. PubMed ID: 19244242 [TBL] [Abstract][Full Text] [Related]
9. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762 [TBL] [Abstract][Full Text] [Related]
10. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520 [TBL] [Abstract][Full Text] [Related]
11. WNK1 and WNK4 modulate CFTR activity. Yang CL; Liu X; Paliege A; Zhu X; Bachmann S; Dawson DC; Ellison DH Biochem Biophys Res Commun; 2007 Feb; 353(3):535-40. PubMed ID: 17194447 [TBL] [Abstract][Full Text] [Related]
12. ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation. Murthy M; Kurz T; O'Shaughnessy KM Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27378813 [TBL] [Abstract][Full Text] [Related]
13. Intersectin links WNK kinases to endocytosis of ROMK1. He G; Wang HR; Huang SK; Huang CL J Clin Invest; 2007 Apr; 117(4):1078-87. PubMed ID: 17380208 [TBL] [Abstract][Full Text] [Related]
14. WNK kinases and the control of blood pressure. Cope G; Golbang A; O'Shaughnessy KM Pharmacol Ther; 2005 May; 106(2):221-31. PubMed ID: 15866321 [TBL] [Abstract][Full Text] [Related]
15. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice. Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705 [TBL] [Abstract][Full Text] [Related]
16. WNK1 kinase isoform switch regulates renal potassium excretion. Wade JB; Fang L; Liu J; Li D; Yang CL; Subramanya AR; Maouyo D; Mason A; Ellison DH; Welling PA Proc Natl Acad Sci U S A; 2006 May; 103(22):8558-63. PubMed ID: 16709664 [TBL] [Abstract][Full Text] [Related]
17. Comparison of WNK4 and WNK1 kinase and inhibiting activities. Wang Z; Yang CL; Ellison DH Biochem Biophys Res Commun; 2004 May; 317(3):939-44. PubMed ID: 15081430 [TBL] [Abstract][Full Text] [Related]
18. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Vitari AC; Deak M; Morrice NA; Alessi DR Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of type I and type II pseudohypoaldosteronism. Furgeson SB; Linas S J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]